Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2 1120,"Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20.",kidney sympathetic nerve activity,,RS:0000770,SHRSP/Izm,male,98 days,6,,CMO:0001786,stimulated renal sympathetic nerve activity to basal renal sympathetic nerve activity ratio,,percent change rsna,,261,%,36.0,88.1816,MMO:0000405,implanted wire electrode recording method,,0.0,,,,,air-jet exposure (for 0 hours),84541,air-jet exposure (for 0 hours), 1120,"Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20.",arterial blood pressure trait,,RS:0000770,SHRSP/Izm,male,98 days,6,,CMO:0002035,percent change in mean arterial blood pressure,,,,28,%,2.0,4.899,MMO:0000011,vascular indwelling catheter method,,0.0,,,,,air-jet exposure (for 0 hours),84544,air-jet exposure (for 0 hours), 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",urine norepinephrine amount,,RS:0000770,SHRSP/Izm,male,84 days,10,,CMO:0001634,absolute change in urine norepinephrine level,,nmol/6h,,95.33333333524,nmol/h,,,MMO:0000394,high-performance liquid chromatography,,0.0,,,,,cold ambient air exposure (4 degrees C) (for 6 hours),84604,cold ambient air exposure (4 degrees C) (for 6 hours), 1498,NBRP Hematology & Blood Biochemistry data,blood albumin amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000056,plasma albumin level,,,,0.4,g/l,0.0082,0.02,MMO:0000351,automated plasma albumin analysis,,,"Hitachi, model 7170 ",,,,fasting (for 16 hours),79814,fasting (for 16 hours), 971,"Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9.",urine vanillylmandelic acid amount,,RS:0000770,SHRSP/Izm,not specified,0 days,6,,CMO:0002571,urine vanillylmandelic acid excretion rate,,urine vanillylmandelic acid exretion rate,,2700,pmol/4h,40.8248,100.0,MMO:0000394,high-performance liquid chromatography,,0.0,hplc,,,,cold ambient air exposure (4 degrees C) (for 4 hours),68661,cold ambient air exposure (4 degrees C) (for 4 hours), 971,"Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9.",urine vanillylmandelic acid amount,,RS:0000770,SHRSP/Izm,not specified,0 days,6,,CMO:0002571,urine vanillylmandelic acid excretion rate,,urine vanillylmandelic acid exretion rate,,1660,pmol/4h,93.8971,230.0,MMO:0000394,high-performance liquid chromatography,,0.0,hplc,,,,room temperature (for 4 hours) then cold ambient air exposure (4 degrees C) (for 4 hours),68664,room temperature (for 4 hours),cold ambient air exposure (4 degrees C) (for 4 hours) 971,"Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9.",urine norepinephrine amount,,RS:0000770,SHRSP/Izm,not specified,0 days,6,,CMO:0002569,urine norepinephrine excretion rate,,urine norepinephrine excretion rate,,6330,pmol/4h,326.5986,800.0,MMO:0000394,high-performance liquid chromatography,,0.0,hplc,,,,cold ambient air exposure (4 degrees C) (for 4 hours),68655,cold ambient air exposure (4 degrees C) (for 4 hours), 971,"Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9.",urine norepinephrine amount,,RS:0000770,SHRSP/Izm,not specified,0 days,6,,CMO:0002569,urine norepinephrine excretion rate,,absolute change in urine norepinephrine excretion rate,,3490,pmol/4h,506.2279,1240.0,MMO:0000394,high-performance liquid chromatography,,0.0,hplc,,,,room temperature (for 4 hours) then cold ambient air exposure (4 degrees C) (for 4 hours),68658,room temperature (for 4 hours),cold ambient air exposure (4 degrees C) (for 4 hours) 1498,NBRP Hematology & Blood Biochemistry data,blood triglyceride amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000548,plasma triglyceride level,,,,0.2938,mmol/l,0.0323,0.0791,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),79820,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,erythrocyte quantity,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000025,red blood cell count,,,,9.5,x 10E6 cells/ul,0.1184,0.29,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),79800,fasting (for 16 hours), 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",epididymal fat pad mass,,RS:0000770,SHRSP/Izm,male,91 days,5,,CMO:0000658,epididymal fat pad weight to body weight ratio,,,,1.1083,%,0.063,0.1409,MMO:0000005,post excision weight measurement,testis,0,,,,,control condition (for 63 days),64996,control condition (for 63 days), 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",blood acidity-alkalinity balance trait,,RS:0000770,SHRSP/Izm,male,150 days,5,,CMO:0000379,blood pH,,,,7.46,,0.0089,0.02,MMO:0000290,blood pH analysis,,0,,,,,control condition,65527,control condition, 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",blood acidity-alkalinity balance trait,,RS:0000770,SHRSP/Izm,male,84 days to 70 days,8,,CMO:0000379,blood pH,,,,7.4,,0.0071,0.02,MMO:0000290,blood pH analysis,,0,,,,,control condition,65528,control condition, 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",blood acidity-alkalinity balance trait,,RS:0000770,SHRSP/Izm,male,150 days,7,,CMO:0000379,blood pH,,,,7.44,,0.0113,0.03,MMO:0000290,blood pH analysis,,0,,,,,control condition,65529,control condition, 1498,NBRP Hematology & Blood Biochemistry data,blood hemoglobin amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000026,blood hemoglobin level,,,,16.8,g/dl,0.1225,0.3,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),79801,fasting (for 16 hours), 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",retroperitoneal fat pad mass,,RS:0000770,SHRSP/Izm,male,91 days,5,,CMO:0000635,retroperitoneal fat pad weight to body weight ratio,,,,0.761,%,0.055,0.123,MMO:0000005,post excision weight measurement,,0,,,,,control condition (0 null) ,64841,control condition (0 null) , 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",retroperitoneal fat pad mass,,RS:0000770,SHRSP/Izm,female,91 days,5,,CMO:0000635,retroperitoneal fat pad weight to body weight ratio,,,,0.666,%,0.034,0.076,MMO:0000005,post excision weight measurement,,0,,,,,control condition (0 null) ,64845,control condition (0 null) , 41,NBRP Organ Weight data,lung mass,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000097,lung wet weight,,,,0.912,g,0.0229,0.056,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,72861,specific pathogen-free condition, 41,NBRP Organ Weight data,spleen mass,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000149,spleen weight to body weight ratio,,,,0.182,%,0.002,0.005,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,72870,specific pathogen-free condition, 1120,"Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20.",arterial blood pressure trait,,RS:0000770,SHRSP/Izm,male,98 days,6,,CMO:0000533,absolute change in mean arterial blood pressure,,,,-102,mmHg,5.0,12.2474,MMO:0000011,vascular indwelling catheter method,,0.0,,,,,air-jet exposure (for 0 hours) then hexamethonium (40 mg/kg) ,69091,air-jet exposure (for 0 hours),hexamethonium (40 mg/kg) 1120,"Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20.",arterial blood pressure trait,,RS:0000770,SHRSP/Izm,male,98 days,6,,CMO:0000533,absolute change in mean arterial blood pressure,,,,47,mmHg,1.0,2.4495,MMO:0000011,vascular indwelling catheter method,,0.0,,,,,air-jet exposure (for 0 hours),84542,air-jet exposure (for 0 hours), 1498,NBRP Hematology & Blood Biochemistry data,erythrocyte size trait,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000038,mean corpuscular volume,,,,57.4,fl,1.1431,2.8,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),79803,fasting (for 16 hours), 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",arterial blood pressure trait,,RS:0000770,SHRSP/Izm,male,150 days,17,,CMO:0000009,mean arterial blood pressure,,,,241,mmHg,5.3358,22.0,MMO:0000013,vascular fluid filled catheter,right femoral artery,0,,,,,control condition,65293,control condition, 1120,"Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20.",arterial blood pressure trait,,RS:0000770,SHRSP/Izm,male,98 days,6,,CMO:0000009,mean arterial blood pressure,,,,175,mmHg,6.0,14.6969,MMO:0000011,vascular indwelling catheter method,,0.0,,,,,control condition,69085,control condition, 22,NBRP Body Temperature data,body temperature trait,,RS:0000770,SHRSP/Izm,male,70 days to 56 days,6,,CMO:0000015,body temperature,,,serial mean,38.1,degrees C,0.1225,0.3,MMO:0000034,digital rectal thermometry,,,,,,,specific pathogen-free condition,75185,specific pathogen-free condition, 41,NBRP Organ Weight data,kidney mass,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000140,both kidneys wet weight as percentage of body weight,,,,0.761,%,0.0094,0.023,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,72866,specific pathogen-free condition, 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",blood oxygen amount,,RS:0000770,SHRSP/Izm,male,84 days to 70 days,8,,CMO:0000381,partial pressure of blood oxygen,,,,111,mmHg,3.182,9.0,MMO:0000175,automated blood gas analysis,,0,,,,,control condition,65511,control condition, 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",blood oxygen amount,,RS:0000770,SHRSP/Izm,male,150 days,5,,CMO:0000381,partial pressure of blood oxygen,,,,119,mmHg,4.0249,9.0,MMO:0000175,automated blood gas analysis,,0,,,,,control condition,65512,control condition, 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",blood oxygen amount,,RS:0000770,SHRSP/Izm,male,150 days,7,,CMO:0000381,partial pressure of blood oxygen,,,,98,mmHg,4.5356,12.0,MMO:0000175,automated blood gas analysis,,0,,,,,control condition,65513,control condition, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",blood triglyceride amount,,RS:0000770,SHRSP/Izm,male,91 days,5,,CMO:0000360,serum triglyceride level,,,,57.5224,mg/dl,10.6195,23.746,MMO:0000136,serum triglyceride analysis,,0,,,,,fasting (0 null) (for 16 hours),64856,fasting (0 null) (for 16 hours), 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",blood triglyceride amount,,RS:0000770,SHRSP/Izm,female,91 days,5,,CMO:0000360,serum triglyceride level,,,,50.44272,mg/dl,11.5045,25.7248,MMO:0000136,serum triglyceride analysis,,0,,,,,fasting (0 null) (for 16 hours),64859,fasting (0 null) (for 16 hours), 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",erythrocyte quantity,,RS:0000770,SHRSP/Izm,male,84 days to 70 days,8,,CMO:0000037,hematocrit,,,,42,%,0.7071,2.0,MMO:0000214,hematocrit analysis,,0,,,,,control condition,65523,control condition, 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",erythrocyte quantity,,RS:0000770,SHRSP/Izm,male,150 days,7,,CMO:0000037,hematocrit,,,,44,%,1.1339,3.0,MMO:0000214,hematocrit analysis,,0,,,,,control condition,65524,control condition, 1498,NBRP Hematology & Blood Biochemistry data,erythrocyte quantity,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000037,hematocrit,,,,54.6,%,1.4289,3.5,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),79802,fasting (for 16 hours), 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",cerebrovascular system integrity trait,,RS:0000770,SHRSP/Izm,male,98 days,12,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,50,%,,,MMO:0000111,ex vivo light microscopy,MA:0000168,0,,,,,controlled sodium content drinking water (1 %) (for 14 days),65291,controlled sodium content drinking water (1 %) (for 14 days), 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",cerebrovascular system integrity trait,,RS:0000770,SHRSP/Izm,female,98 days,10,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,0,%,,,MMO:0000111,ex vivo light microscopy,MA:0000168,0,,,,,controlled sodium content drinking water (1 %) (for 14 days),65292,controlled sodium content drinking water (1 %) (for 14 days), 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",cerebrovascular system integrity trait,,RS:0000770,SHRSP/Izm,male,112 days,12,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,100,%,,,MMO:0000111,ex vivo light microscopy,MA:0000168,0,,,,,controlled sodium content drinking water (1 %) (for 28 days),65294,controlled sodium content drinking water (1 %) (for 28 days), 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",cerebrovascular system integrity trait,,RS:0000770,SHRSP/Izm,female,112 days,10,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,60,%,,,MMO:0000111,ex vivo light microscopy,MA:0000168,0,,,,,controlled sodium content drinking water (1 %) (for 28 days),65295,controlled sodium content drinking water (1 %) (for 28 days), 41,NBRP Organ Weight data,brain mass,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000139,brain weight to body weight ratio,,,,0.83,%,0.0159,0.039,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,72858,specific pathogen-free condition, 41,NBRP Organ Weight data,liver mass,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000141,liver weight as percentage of body weight,,,,2.908,%,0.0372,0.091,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,72864,specific pathogen-free condition, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",blood cholesterol amount,,RS:0000770,SHRSP/Izm,male,91 days,5,,CMO:0000363,serum total cholesterol level,,,,54.8262,mg/dl,1.9305,4.3167,MMO:0000132,serum total cholesterol measurement test,,0,,,,,fasting (0 null) (for 16 hours),64850,fasting (0 null) (for 16 hours), 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",blood cholesterol amount,,RS:0000770,SHRSP/Izm,female,91 days,5,,CMO:0000363,serum total cholesterol level,,,,67.5675,mg/dl,2.3166,5.1801,MMO:0000132,serum total cholesterol measurement test,,0,,,,,fasting (0 null) (for 16 hours),64853,fasting (0 null) (for 16 hours), 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",arterial blood pressure trait,,RS:0000770,SHRSP/Izm,male,91 days,5,,CMO:0000004,systolic blood pressure,,,,219.6,mmHg,6.8,15.2053,MMO:0000031,tail cuff plethysmography,,,,,0,,control condition,11678,control condition, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",arterial blood pressure trait,,RS:0000770,SHRSP/Izm,female,91 days,5,,CMO:0000004,systolic blood pressure,,,,200.2,mmHg,8.7,19.4538,MMO:0000031,tail cuff plethysmography,,,,,0,,control condition,11681,control condition, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0000770,SHRSP/Izm,male,84 days,18,,CMO:0000004,systolic blood pressure,,avg of 5 measurements for,serial mean,213,mmHg,,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,84602,control condition, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0000770,SHRSP/Izm,male,94 days,N/A,,CMO:0000004,systolic blood pressure,,avg of 5 measurements for,serial mean,213,mmHg,,31.0,MMO:0000015,radiotelemetry,,0.0,,,,,controlled visible light exposure,84616,controlled visible light exposure, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0000770,SHRSP/Izm,male,94 days,N/A,,CMO:0000004,systolic blood pressure,,avg of 5 measurements for,serial mean,226,mmHg,,30.0,MMO:0000015,radiotelemetry,,0.0,,,,,controlled exposure to darkness,84618,controlled exposure to darkness, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0000770,SHRSP/Izm,male,84 days,18,,CMO:0000004,systolic blood pressure,,avg of 5 measurements for,serial mean,213,mmHg,3.7712,16.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,84620,control condition, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000770,SHRSP/Izm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,190,mmHg,4.4907,11.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75183,specific pathogen-free condition, 41,NBRP Organ Weight data,lung mass,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000156,lung weight to body weight ratio,,,,0.407,%,0.0065,0.016,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,72862,specific pathogen-free condition, 41,NBRP Organ Weight data,liver mass,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000158,liver wet weight,,,,6.515,g,0.1858,0.455,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,72863,specific pathogen-free condition, 1498,NBRP Hematology & Blood Biochemistry data,blood creatinine amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000537,plasma creatinine level,,,,0.28,mg/dl,0.0122,0.03,MMO:0000354,automated plasma creatinine analysis,,,"Hitachi, model 7170 ",,,,fasting (for 16 hours),79823,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,blood cholesterol amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000585,plasma total cholesterol level,,,,60,mg/dl,2.4495,6.0,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),79817,fasting (for 16 hours), 41,NBRP Organ Weight data,adrenal gland mass,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000164,both adrenal glands wet weight,,,,41.6,mg,1.1023,2.7,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,72867,specific pathogen-free condition, 1498,NBRP Hematology & Blood Biochemistry data,blood glucose amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000042,plasma glucose level,,,,165,mg/dl,5.7155,14.0,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),79816,fasting (for 16 hours), 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",blood carbon dioxide amount,,RS:0000770,SHRSP/Izm,male,84 days to 70 days,8,,CMO:0000283,partial pressure of blood carbon dioxide (Pco2),,,,40.6,mmHg,0.8485,2.4,MMO:0000175,automated blood gas analysis,,0,,,,,control condition,65514,control condition, 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",blood carbon dioxide amount,,RS:0000770,SHRSP/Izm,male,150 days,5,,CMO:0000283,partial pressure of blood carbon dioxide (Pco2),,,,42.2,mmHg,0.9839,2.2,MMO:0000175,automated blood gas analysis,,0,,,,,control condition,65515,control condition, 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",blood carbon dioxide amount,,RS:0000770,SHRSP/Izm,male,150 days,7,,CMO:0000283,partial pressure of blood carbon dioxide (Pco2),,,,39.7,mmHg,0.9071,2.4,MMO:0000175,automated blood gas analysis,,0,,,,,control condition,65516,control condition, 1120,"Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20.",heart pumping trait,,RS:0000770,SHRSP/Izm,male,98 days,6,,CMO:0000002,heart rate,,,,287,beats/min,5.0,12.2474,MMO:0000011,vascular indwelling catheter method,,0.0,,,,,control condition,69088,control condition, 14,NBRP Blood Pressure and Heart Rate data,heart pumping trait,,RS:0000770,SHRSP/Izm,male,70 days to 56 days,6,,CMO:0000002,heart rate,,,serial mean,445,beats/min,24.9031,61.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75184,specific pathogen-free condition, 41,NBRP Organ Weight data,brain mass,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000155,brain wet weight,,,,1.854,g,0.0151,0.037,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,72857,specific pathogen-free condition, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",blood glucose amount,,RS:0000770,SHRSP/Izm,male,91 days,5,,CMO:0000042,plasma glucose level,,,,141.84,mg/dl,4.32,9.6598,MMO:0000112,blood glucose analysis,,0,,,,,fasting (0 null) (for 16 hours),64868,fasting (0 null) (for 16 hours), 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",blood glucose amount,,RS:0000770,SHRSP/Izm,female,91 days,5,,CMO:0000042,plasma glucose level,,,,134.46,mg/dl,13.14,29.3819,MMO:0000112,blood glucose analysis,,0,,,,,fasting (0 null) (for 16 hours),64871,fasting (0 null) (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,blood hemoglobin amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000291,mean corpuscular hemoglobin concentration,,,,30.9,g/dl,0.7757,1.9,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),79805,fasting (for 16 hours), 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",blood free fatty acid amount,,RS:0000770,SHRSP/Izm,male,91 days,5,,CMO:0000547,serum free fatty acids level,,,,0.61,mmol/l,0.08,0.1789,MMO:0000308,serum free fatty acid analysis,,0,,,,,fasting (0 null) (for 16 hours),64862,fasting (0 null) (for 16 hours), 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",blood free fatty acid amount,,RS:0000770,SHRSP/Izm,female,91 days,5,,CMO:0000547,serum free fatty acids level,,,,0.6,mmol/l,0.05,0.1118,MMO:0000308,serum free fatty acid analysis,,0,,,,,fasting (0 null) (for 16 hours),64865,fasting (0 null) (for 16 hours), 41,NBRP Organ Weight data,heart mass,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000069,heart wet weight,,,,0.997,g,0.0208,0.051,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,72859,specific pathogen-free condition, 41,NBRP Organ Weight data,kidney mass,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000085,both kidneys wet weight,,,,1.704,g,0.0396,0.097,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,72865,specific pathogen-free condition, 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",body mass,,RS:0000770,SHRSP/Izm,male,150 days,17,,CMO:0000012,body weight,,,,315,g,7.2761,30.0,MMO:0000016,body weighing method,,0,,,,,control condition,65509,control condition, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",body mass,,RS:0000770,SHRSP/Izm,male,91 days,5,,CMO:0000012,body weight,,,,245.4,g,5.9,13.1928,MMO:0000016,body weighing method,,0,,,,,control condition (0 null) ,64828,control condition (0 null) , 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",body mass,,RS:0000770,SHRSP/Izm,female,91 days,5,,CMO:0000012,body weight,,,,160.6,g,3.6,8.0498,MMO:0000016,body weighing method,,0,,,,,control condition (0 null) ,64831,control condition (0 null) , 1498,NBRP Hematology & Blood Biochemistry data,blood hemoglobin amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000290,mean corpuscular hemoglobin,,,,17.7,pg,0.1633,0.4,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),79804,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,blood HDL cholesterol amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000646,plasma high density lipoprotein cholesterol level,,,,38.6,mg/dl,1.7146,4.2,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),79818,fasting (for 16 hours), 41,NBRP Organ Weight data,testis mass,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000175,both testes wet weight,,,,2.713,g,0.078,0.191,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,72871,specific pathogen-free condition, 1498,NBRP Hematology & Blood Biochemistry data,blood LDL cholesterol amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000647,plasma low density lipoprotein cholesterol level,,,,6,mg/dl,0.4082,1.0,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),79819,fasting (for 16 hours), 41,NBRP Organ Weight data,testis mass,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000901,both testes wet weight to body weight ratio,,,,1.212,%,0.0245,0.06,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,72872,specific pathogen-free condition, 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",head temperature trait,,RS:0000770,SHRSP/Izm,male,150 days,7,,CMO:0001035,head temperature,,,,36.3,degrees C,0.0756,0.2,MMO:0000193,in vivo thermometry,,0,,,,,control condition,65957,control condition, 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",head temperature trait,,RS:0000770,SHRSP/Izm,male,150 days,7,,CMO:0001035,head temperature,,,,36.3,degrees C,0.189,0.5,MMO:0000193,in vivo thermometry,,0,,,,,control condition,65961,control condition, 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",head temperature trait,,RS:0000770,SHRSP/Izm,male,84 days to 70 days,8,,CMO:0001035,head temperature,,,,36.4,degrees C,0.1061,0.3,MMO:0000193,in vivo thermometry,,0,,,,,control condition,65953,control condition, 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",body temperature trait,,RS:0000770,SHRSP/Izm,male,150 days,7,,CMO:0001036,core body temperature,,,,37.4,degrees C,0.189,0.5,MMO:0000193,in vivo thermometry,,0,,,,,control condition (for 150 days),65958,control condition (for 150 days), 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",body temperature trait,,RS:0000770,SHRSP/Izm,male,150 days,7,,CMO:0001036,core body temperature,,,,37.7,degrees C,0.2268,0.6,MMO:0000193,in vivo thermometry,,0,,,,,control condition (for 150 days),65962,control condition (for 150 days), 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",body temperature trait,,RS:0000770,SHRSP/Izm,male,84 days to 70 days,8,,CMO:0001036,core body temperature,,,,37.4,degrees C,0.1061,0.3,MMO:0000193,in vivo thermometry,,0,,,,,control condition (between 70 and 84 days),65954,control condition (between 70 and 84 days), 41,NBRP Organ Weight data,spleen mass,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000171,spleen wet weight,,,,0.407,g,0.009,0.022,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,72869,specific pathogen-free condition, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0000770,SHRSP/Izm,male,94 days,4,,CMO:0000607,absolute change in systolic blood pressure,,avg of 5 measurements for,serial mean,23,mmHg,,,MMO:0000015,radiotelemetry,,0.0,,,,,physical restraint in mechanical restrainer (for 3 hours),84605,physical restraint in mechanical restrainer (for 3 hours), 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0000770,SHRSP/Izm,male,94 days,4,,CMO:0000607,absolute change in systolic blood pressure,,avg of 5 measurements for,serial mean,35,mmHg,,,MMO:0000015,radiotelemetry,,0.0,,,,,cold ambient air exposure (4 degrees C) (for 3 hours),84606,cold ambient air exposure (4 degrees C) (for 3 hours), 634,"Iigaya K, et al., Hypertension. 2008 Dec 1.",action potential trait,,RS:0000770,SHRSP/Izm,not specified,4 days to 0 days,7,,CMO:0000231,cell membrane potential,,regularly firing neurons,,-45.4,mV,1.3607,3.6,MMO:0000293,whole-cell patch clamp technique,,600,,,,,control condition,65896,control condition, 634,"Iigaya K, et al., Hypertension. 2008 Dec 1.",action potential trait,,RS:0000770,SHRSP/Izm,not specified,4 days to 0 days,8,,CMO:0000231,cell membrane potential,,irregularly firing neurons,,-50,mV,0.0,0.0,MMO:0000293,whole-cell patch clamp technique,,600,,,,,control condition,65900,control condition, 567,"Yao H, et al., Physiol Genomics. 2007 Feb 27;.",brain integrity trait,,RS:0000770,SHRSP/Izm,male,153 days,17,,CMO:0001013,brain infarction volume,,,,103.4,mm3,6.0149,24.8,MMO:0000111,ex vivo light microscopy,,0,,MCA occlusion,3,days,control condition (for 153 days),65951,control condition (for 153 days), 41,NBRP Organ Weight data,adrenal gland mass,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000621,both adrenal glands weight to body weight ratio,,,,18.6,mg/100g,0.5715,1.4,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,72868,specific pathogen-free condition, 21,NBRP Body Weight data,body mass,,RS:0000770,SHRSP/Izm,male,35 days,6,,CMO:0000012,body weight,,,,105.4,g,1.8371,4.5,MMO:0000017,whole body digital scale,,,,,,,specific pathogen-free condition,70929,specific pathogen-free condition, 21,NBRP Body Weight data,body mass,,RS:0000770,SHRSP/Izm,male,42 days,6,,CMO:0000012,body weight,,,,140.7,g,2.1637,5.3,MMO:0000017,whole body digital scale,,,,,,,specific pathogen-free condition,70930,specific pathogen-free condition, 21,NBRP Body Weight data,body mass,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000012,body weight,,,,236.2,g,3.96,9.7,MMO:0000017,whole body digital scale,,,,,,,specific pathogen-free condition,70928,specific pathogen-free condition, 1498,NBRP Hematology & Blood Biochemistry data,blood urea nitrogen amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000586,plasma urea nitrogen level,,,,7.6398,mmol/l,0.4664,1.1424,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),79822,fasting (for 16 hours), 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",heart pumping trait,,RS:0000770,SHRSP/Izm,male,91 days,5,,CMO:0002162,absolute change in electrocardiographic low frequency R-R spectral component to high frequency R-R spectral component ratio,,avg of 5 measurements for,serial mean,3.39,,,,MMO:0000507,wire electrode telemetric electrocardiography with power spectral analysis,,0.0,,,,,physical restraint in mechanical restrainer (for 3 hours),84603,physical restraint in mechanical restrainer (for 3 hours), 1498,NBRP Hematology & Blood Biochemistry data,blood total protein amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000054,plasma total protein level,,,,67,mg/ml,1.2247,3.0,MMO:0000356,automated plasma total protein analysis,,,"Hitachi, model 7170 ",,,,fasting (for 16 hours),79813,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,basophil quantity,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000368,blood basophil count to total leukocyte count ratio,,,,0,%,0.0,0.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),79829,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,blood phosphate amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000058,plasma phosphate level,,,,5.5,mg/dl,0.4491,1.1,MMO:0000037,automated blood electrolyte analysis,,,"Hitachi, model 7170 ",,,,fasting (for 16 hours),79824,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,blood coagulation trait,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000210,activated partial thromboplastin time,,,,14.5,s,0.7757,1.9,MMO:0000178,automated coagulometer method,,,"Sysmex, CA-3000 type",,,,fasting (for 16 hours),79809,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,blood coagulation trait,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000211,prothrombin time,,,,16.7,s,0.2041,0.5,MMO:0000178,automated coagulometer method,,,"Sysmex, CA-3000 type",,,,fasting (for 16 hours),79808,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,eosinophil quantity,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000369,blood eosinophil count to total leukocyte count ratio,,,,1,%,0.4082,1.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),79830,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,lymphocyte quantity,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000371,blood lymphocyte count to total leukocyte count ratio,,,,70,%,2.4495,6.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),79833,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,monocyte quantity,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000374,blood monocyte count to total leukocyte count ratio,,,,0,%,0.0,0.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),79834,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,blood calcium amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000378,total plasma calcium level,,,,10.1,mg/dl,0.1225,0.3,MMO:0000037,automated blood electrolyte analysis,,,"Hitachi, model 7170 ",,,,fasting (for 16 hours),79825,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,blood alkaline phosphatase amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000045,plasma alkaline phosphatase activity level,,,,393,IU/l,7.3485,18.0,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),79812,fasting (for 16 hours), 1662,NBRP Urine Volume and Urine Electrolyte data,urine chloride amount,,RS:0000770,SHRSP/Izm,male,63 days,6,,CMO:0000382,urine chloride level,,,,155,mEq/L,11.0227,27.0,MMO:0000177,automated urine analysis,,,,,,,0.9% sodium chloride solution (25 ml/kg) ,95530,0.9% sodium chloride solution (25 ml/kg) , 1662,NBRP Urine Volume and Urine Electrolyte data,urine potassium amount,,RS:0000770,SHRSP/Izm,male,63 days,6,,CMO:0002159,urine potassium excretion rate to body weight ratio,,,,124,uEq/100g/6 hrs,8.5732,21.0,MMO:0000177,automated urine analysis,,,"Analytical intruments, PVA alpha II",,,,0.9% sodium chloride solution (25 ml/kg) ,95529,0.9% sodium chloride solution (25 ml/kg) , 1662,NBRP Urine Volume and Urine Electrolyte data,urine chloride amount,,RS:0000770,SHRSP/Izm,male,63 days,6,,CMO:0002158,urine chloride excretion rate to body weight ratio,,,,234,uEq/100g/6 hrs,8.5732,21.0,MMO:0000177,automated urine analysis,,,,,,,0.9% sodium chloride solution (25 ml/kg) ,95531,0.9% sodium chloride solution (25 ml/kg) , 1498,NBRP Hematology & Blood Biochemistry data,leukocyte quantity,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000027,white blood cell count,,,,2.5,x 1000 cells/ul,0.3266,0.8,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),79806,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,platelet quantity,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000029,platelet count,,,,647,x 1000 /ul,39.1918,96.0,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),79807,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,blood bilirubin amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0002334,plasma total bilirubin level,,total plasma bilirubin level,,0.05,mg/dl,0.0041,0.01,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),79821,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,blood sodium amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000060,plasma sodium level,,,,146.5,mmol/l,0.2449,0.6,MMO:0000037,automated blood electrolyte analysis,,,"Analytical intruments, PVA alpha II",,,,fasting (for 16 hours),79826,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,blood potassium amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000061,plasma potassium level,,,,4.6,mmol/l,0.7798,1.91,MMO:0000037,automated blood electrolyte analysis,,,"Analytical intruments, PVA alpha II",,,,fasting (for 16 hours),79827,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,blood chloride amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000059,plasma chloride level,,,,108,mmol/l,0.4082,1.0,MMO:0000037,automated blood electrolyte analysis,,,"Analytical intruments, PVA alpha II",,,,fasting (for 16 hours),79828,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,blood aspartate transaminase amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000043,plasma aspartate aminotransferase activity level,,,,86,U/l,1.633,4.0,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),79810,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,blood alanine transaminase amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000044,plasma alanine aminotransferase activity level,,,,45,U/l,0.8165,2.0,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),79811,fasting (for 16 hours), 1662,NBRP Urine Volume and Urine Electrolyte data,urine potassium amount,,RS:0000770,SHRSP/Izm,male,63 days,6,,CMO:0000128,urine potassium level,,,,80.7,mmol/l,4.9806,12.2,MMO:0000177,automated urine analysis,,,"Analytical intruments, PVA alpha II",,,,0.9% sodium chloride solution (25 ml/kg) ,95528,0.9% sodium chloride solution (25 ml/kg) , 1662,NBRP Urine Volume and Urine Electrolyte data,urine sodium amount,,RS:0000770,SHRSP/Izm,male,63 days,6,,CMO:0000129,urine sodium level,,,,126.1,mmol/l,9.9204,24.3,MMO:0000177,automated urine analysis,,,"Analytical intruments, PVA alpha II",,,,0.9% sodium chloride solution (25 ml/kg) ,95526,0.9% sodium chloride solution (25 ml/kg) , 1662,NBRP Urine Volume and Urine Electrolyte data,urine output,,RS:0000770,SHRSP/Izm,male,63 days,6,,CMO:0000260,timed urine volume,,,,14.4,ml/d,0.7348,1.8,MMO:0000511,metabolic cage urine volume measurement method,,,,,,,0.9% sodium chloride solution (25 ml/kg) ,95524,0.9% sodium chloride solution (25 ml/kg) , 1662,NBRP Urine Volume and Urine Electrolyte data,urine sodium amount,,RS:0000770,SHRSP/Izm,male,63 days,6,,CMO:0001855,urine sodium excretion rate to body weight ratio,,,,0.005348,uEq/min/g,3.0E-4,7.0E-4,MMO:0000177,automated urine analysis,,,"Analytical intruments, PVA alpha II",,,,0.9% sodium chloride solution (25 ml/kg) ,95527,0.9% sodium chloride solution (25 ml/kg) , 1662,NBRP Urine Volume and Urine Electrolyte data,urine output,,RS:0000770,SHRSP/Izm,male,63 days,6,,CMO:0001968,timed urine volume to body weight ratio,,,,0.042,ul/min/g,0.0023,0.0056,MMO:0000511,metabolic cage urine volume measurement method,,,,,,,0.9% sodium chloride solution (25 ml/kg) ,95525,0.9% sodium chloride solution (25 ml/kg) , 1498,NBRP Hematology & Blood Biochemistry data,neutrophil quantity,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0002337,blood segmented neutrophil count to total leukocyte count ratio,,segmented neutrophil %,,29,%,2.0412,5.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),79832,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,blood albumin amount,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0002342,plasma albumin to plasma total protein ratio,,plasma albumin to plasma total protein ratio,,1.53,,0.0245,0.06,MMO:0000352,automated plasma protein analysis,,,"Hitachi, model 7170 ",,,,fasting (for 16 hours),79815,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,leukocyte quantity,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0002339,non-specified leukocyte count to total leukocyte count ratio,,unidentified differential wbc,,0,%,0.0,0.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),79835,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,neutrophil quantity,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0002338,blood band neutrophil count to total leukocyte count ratio,,band neutrophil %,,0,%,0.0,0.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),79831,fasting (for 16 hours), 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",heart mass,,RS:0000770,SHRSP/Izm,male,91 days,5,,CMO:0000074,heart weight to body weight ratio,,,,4.07,g/kg,0.12,0.2683,MMO:0000005,post excision weight measurement,,0,,,,,control condition (0 null) ,64835,control condition (0 null) , 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",heart mass,,RS:0000770,SHRSP/Izm,female,91 days,5,,CMO:0000074,heart weight to body weight ratio,,,,4.84,g/kg,0.24,0.5367,MMO:0000005,post excision weight measurement,,0,,,,,control condition (0 null) ,64838,control condition (0 null) , 41,NBRP Organ Weight data,heart mass,,RS:0000770,SHRSP/Izm,male,70 days,6,,CMO:0000074,heart weight to body weight ratio,,,,4.45,g/kg,0.0898,0.22,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,72860,specific pathogen-free condition,